Karyopharm Therapeutics Inc (KPTI) financials · rev $146.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Karyopharm Therapeutics Inc (KPTI) rev $146.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $146.1M | $145.2M |
| Operating Income | -$90.7M | -$119.4M |
| Net Income | -$196.0M | -$76.4M |
| EPS (Diluted) | -$17.93 | -$0.93 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $108.4M | $164.4M |
| Current Assets | $103.1M | $156.5M |
| Cash & Equivalents | $60.5M | $62.5M |
| Inventory | $4.04M | $4.74M |
| PP&E | $104.0K | $400.0K |
| Total Liabilities | $401.3M | $350.4M |
| Current Liabilities | $92.1M | $92.3M |
| Shareholders' Equity | -$292.9M | -$186.0M |
| Retained Earnings | -$1.76B | -$1.56B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$75.4M | -$127.5M |
| CapEx | N/A | $142.0K |
| Investing Cash Flow | $43.4M | $95.5M |
| Financing Cash Flow | $30.0M | $41.6M |
| Net Change in Cash | -$1.92M | $9.62M |
| Free Cash Flow | -$75.4M | -$127.6M |
FAQ
What is KPTI P/E and revenue?
Karyopharm Therapeutics Inc (KPTI) rev $146.1M.
What is KPTI revenue?
Karyopharm Therapeutics Inc last cached revenue is $146.1M (FY2025).
Is KPTI profitable?
Karyopharm Therapeutics Inc last cached net income is -$196.0M (FY2025).
What are KPTI total assets?
Karyopharm Therapeutics Inc last cached total assets are $108.4M (FY2025).
What is KPTI free cash flow?
Karyopharm Therapeutics Inc last cached free cash flow is -$75.4M (FY2025).
Not investment advice. Cached statements, not a live tape.